For years, health care professional (HCP) engagement has rested on a flawed assumption: that more information, delivered ...
Shionogi, Gate Bioscience, and Alector post a trio of new deals, Rajul Jain makes the case for social listening as a medical ...
In today’s global marketplace, supply chain readiness is a necessity. As the pharma industry relies more and more on a global supply chain, the impact of disruptions (both regul ...
Japan launch pricing has become more consequential against the backdrop of the U.S. most-favored-nation (MFN) policy. Japan is included in the reference basket contemplated under ...
CORXEL’s Dr. Bo Liang on why GLP-1 therapies are a broader chronic disease platform — not just obesity drugs — with benefits ...
Jewel Jones warns that pharma catches patient disengagement too late, CSL and Alentis Therapeutics join Jiangsu Nhwa and ...
Social listening can help medical affairs and medical information teams identify knowledge gaps, strengthen scientific exchange and respond to changing stakeholder needs faster and at greater scale.
Under terms of the agreement, IntraBio is expected to become a wholly owned subsidiary of Shionogi Inc., Shionogi's New Jersey-based subsidiary. 1 Shionogi Inc. will also acquire all outstanding ...
Trialbee CEO Matt Walz explores the current impact of AI in delivering practical gains in clinical development and reflects ...
Why effective RWD linkage starts with a specific research objective — and how tokenization, clean rooms, and AI make it possible. Real-world data (RWD) is an essential resource for finding insights ...
Along with rising sales, GLP-1s are a major focus for R&D teams. Major pharma companies are developing new versions of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results